Back to search

France· FR:62424027

INSUMAN INFUSAT 100 UI/ml, solution injectable en cartouche

A medicinal product containing insuline humaine recombinante neutre, registered in France by SANOFI AVENTIS (ALLEMAGNE), on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedINSUMAN INFUSAT 100 UI/ml, solution i…ATC—REGISTER NO.FR:62424027PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
INSULINE HUMAINE RECOMBINANTE NEUTRE
Manufacturer
SANOFI AVENTIS (ALLEMAGNE)
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400934935527
    5 cartouche(s) en verre de 3,15 ml
    EUR 43.81

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Insuline humaine recombinante neutre in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All insuline humaine recombinante neutre products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Huminsulin Basal Kwikpen, Huminsulin Basal Kwikpen Lilly
  • Belgium · Humuline 30/70 Cartridge, Humuline Nph Cartridge
  • Bulgaria · Humulin M3 (Mixture 3), Хумулин N
  • Cyprus · Humulin M3
  • Czechia · Humulin M3 (30/70) Cartridge, Humulin M3 (30/70) Kwikpen
  • Germany · Huminsulin Basal (Nph), Huminsulin Basal (Nph) Kwikpen
  • Denmark · Humulin Nph, Humulin Nph Kwikpen
  • Estonia · Humulin N, Humulin N Kwikpen
  • Spain · Humulina 30:70, Humulina 30:70 Kwikpen
  • United Kingdom (Northern Ireland) · Humulin I (Isophane), Humulin I Kwikpen (Isophane)
  • Greece · Humulin M3, Humulin M3 Kwikpen
  • Croatia · Humulin M3, Humulin N
  • Hungary · Humulin M3 (30/70), Humulin N
  • Ireland · Humulin I (Isophane), Humulin I Kwikpen (Isophane)
  • Italy · Humulin 30/70 (Miscela), Humulin I (Isofano)
  • Lithuania · Humulin N, Humulin N Kwikpen
  • Luxembourg · Humuline 30/70 Cartridge, Humuline Nph Cartridge
  • Latvia · Humulin N, Humulin N Kwikpen
  • Malta · Humulin I (Isophane), Humulin M3 (Mixture 3)
  • Netherlands · Humuline 30/70 Patroon, Humuline Nph Kwikpen
  • Portugal · Humulin M3 (Mistura M3), Humulin Nph
  • Romania · Humulin M3, Humulin M3 Kwikpen
  • Sweden · Humulin Nph, Humulin Nph Kwikpen
  • Slovenia · Humulin M3, Humulin M3 Kwikpen
  • Slovakia · Humulin M3 (30/70) Cartridge, Humulin M3 (30/70) Kwikpen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/49e49348-9ba5-4a6d-adaa-86df2c38e3be
GET /v1/drugs/49e49348-9ba5-4a6d-adaa-86df2c38e3be?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62424027",
  "date_amm": "1998-11-11",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/97/030",
  "substance": "INSULINE HUMAINE RECOMBINANTE NEUTRE",
  "statut_amm": "Autorisation archivée",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about insuline humaine recombinante neutre.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.